NCT02469597 - Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Bronchiolitis

Interventions

DRUG

Furosemide

1 mg/kg intravenous or oral (will give oral unless patient has peripheral IV access in place), maximum dose 10mg (1ml), x 1 dose

DRUG

Placebo

0.1ml/kg intravenous or oral (Normal Saline) (will give oral unless patient has peripheral IV access in place), maximum dose 1ml, x 1 dose

Trial Locations (1)

Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park